에 대한 최신 뉴스 Alzamend Neuro (NASDAQ:ALZN) 주식

Alzamend Neuro

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Stocks Photo by WHYFRAME on Shutterstock

Equities

News

Markets

ALZN

NVDA

PANW

TSLA

월요일 주요 미국 지수들은 상승세로 마감했다. 다우존스 산업평균지수는 0.6% 상승한 40,896.53에 마감했고, S&amp;P 500 지수는 거의 1% 상승한 5,608.25에 마감했다. 나스닥은 가장 큰 상승세를 보이며 17,876.77로 거의 1.4% 상승하며 하루를 마감했다.

월요일 주목받은 주식 5종목: 엔비디아, AMD, 알자멘드 뉴로, 팔로알토 네트웍스, 테슬라

Alzamend Neuro Inc

Swedbank (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SWDBY#OTC">SWDBY</a>) reported quarterly earnings of $0.68 per share. This is a 5.56 percent decrease over earnings of $0.72 per share from the same period last year. The company reported $1.62 billion in sales this quarter. This is a 6.78 percent decrease over sales of $1.74 billion the same period last year.

Earnings

SWDBY

Swedbank Q1 EPS $0.68 Down From $0.72 YoY, Sales $1.62B Down From $1.74B YoY

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Tech investor Chamath Palihapitiya highlighted the rising dominance of stablecoins in the global financial system Tuesday, deeming them one of the hottest cryptocurrency narratives besides Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: As part of his deep dive into the stablecoin market, Palihapitiya noted that stablecoins&#8217; weekly transaction volumes have exceeded that of Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>).
These findings were corroborated by a recent report by asset management firm Bitwise, which <a href="https://s3.us-east-1.amazonaws.com/static.bitwiseinvestments.com/Research/Bitwise-Crypto-Market-Review-Q1-2025.pdf">showed </a>stablecoin transaction volumes overtaking the payments giant by 2024. In 2020, stablecoin volumes were 11% of total VISA volumes.
The dominance led Palihapitiya to call dollar-backed stablecoins, including Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) and USD Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>), the &#8220;second killer app&#8221; in the cryptocurrency space, next to Bitcoin.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Deep Dive: A Primer on Stablecoins Last year, Visa announced the launch of the Visa Tokenized Asset Platform, a new infrastructure designed to help banks issue and manage stablecoins and tokenized deposits. This week, Stripe began testing a stablecoin pilot, aiming to help… <a href="https://t.co/pYpRcA7hEG">pic.twitter.com/pYpRcA7hEG</a>
&mdash; Chamath Palihapitiya (@chamath) <a href="https://twitter.com/chamath/status/1916970964983972070?ref_src=twsrc%5Etfw">April 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Palihapitiya outlined some key developments in the stablecoin market that influenced its growth trajectory. He mentioned Visa&#8217;s&nbsp;launch of the Visa Tokenized&nbsp;Asset Platform, Stripe&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38460707/stripe-makes-a-crypto-comeback-accepts-stablecoins-for-online-payments">stablecoin pilot</a>, and Mastercard&#8217;s&nbsp;new <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44935132/the-quiet-rise-of-the-worlds-new-money-standard">features </a>that allow consumers&nbsp;to spend stablecoins.
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/45058619/arizona-moving-to-convert-up-to-10-of-its-treasury-to-bitcoin-legislature-clears-bills-paving-way-for-strategic-crypto-reserve" target="_blank" rel="noreferrer noopener">Arizona Moving To Convert Up to 10% Of Its Treasury To Bitcoin: Legislature Clears Bills Paving Way For Strategic Crypto Reserve </a>
Why It Matters: The rise of dollar-backed stablecoins has been a hot topic in the cryptocurrency world. According to a&nbsp;multinational bank, Standard Chartered, the <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44812762/stablecoins-to-surge-to-2-trillion-by-2028-says-standard-chartered-heres-what-it-means-for-the-dollar">total value</a> of the stablecoin market is expected to surge from $230 billion today to $2 trillion by the end of 2028, potentially generating $1.6 trillion in additional demand for U.S. Treasury bills.
None other than President Donald Trump has <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44420122/donald-trump-calls-for-stablecoin-legislation-lauds-bitcoin-reserve-biden-got-a-fraction-of-their-value">called on Congress to pass stablecoin legislation</a>, emphasizing the need for clear rules to foster innovation in the cryptocurrency sector. 
The SEC has already stated that stablecoins fully backed by physical U.S. dollars or low-risk, short-term liquid instruments and redeemable at a 1:1 ratio with the U.S. dollar <a href="https://www.benzinga.com/content/44656762/sec-says-certain-stablecoins-qualify-as-non-securities-under-new-guidelines">will be classified as &#8220;non-securities</a>.&#8221;
Price Action: Shares of VISA closed 0.70% higher at $337.51 during Monday&#8217;s regular trading session. The stock exhibited good momentum and quality scores as of this writing. To know more about these metrics and more, check out <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a>.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="505" height="188" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29032855/Screenshot-2025-04-29-125817.png" alt="" class="wp-image-892206" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29032855/Screenshot-2025-04-29-125817.png 505w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29032855/Screenshot-2025-04-29-125817-300x112.png 300w" sizes="(max-width: 505px) 100vw, 505px" /></figure>
Read Next:&nbsp;
<ul>
<li><a href="https://benzinga.com/markets/cryptocurrency/25/04/45039243/xrp-is-the-top-altcoin-bet-10x-research" target="_blank" rel="noreferrer noopener">XRP Is The Top Altcoin Bet: 10x Research</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>
Photo Courtesy: creativeneko on Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$USDC

$USDT

Chamath Palihapitiya Says Stablecoins Are Crypto's 'Second Killer App' After Bitcoin, As Volumes Surpass Visa

Uber Technologies Inc. is rescinding remote work privileges and making in-office attendance mandatory, following months of other tech giants issuing <a href="https://www.benzinga.com/markets/25/04/44971069/google-to-remote-workers-return-to-office-3-days-a-week-or-take-a-buyout-report">similar directives</a>. The new development was announced internally on Monday and is part of a company-wide push to modify operations under CEO Dara Khosrowshahi.
What Happened: From June, Uber employees will have to work from the office three days a week. Currently, only two days are mandatory. This rule will be applicable for workers who had previously been granted remote status. In a memo viewed <a href="https://www.cnbc.com/2025/04/28/uber-raises-in-office-requirement-to-3-days-claws-back-remote-workers.html">by</a> CNBC, Khosrowshahi said, "I want to emphasize that ‘good' is not going to be good enough — we need to be great." 
Tuesday through Thursday have been designated as mandatory in-office days. The company is also phasing out most new fully remote recruits and reconsidering work-from-home arrangements it had granted earlier.
Uber did not immediately respond to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/news/global/25/04/44877914/from-s-o-paulo-to-sofia-the-emerging-region-hiring-boom-powering-americas-remote-workforce">From São Paulo to Sofia: The Emerging‑Region Hiring Boom Powering America&#8217;s Remote Workforce</a>
Why It Matters: With this move, Uber&#8217;s leadership has underlined its belief that in-person work improves performance. "Being in the office fuels collaboration, sparks creativity, and increases velocity," Khosrowshahi wrote. 
Corporate giants are <a href="https://www.benzinga.com/25/03/44300682/jamie-dimon-doubles-down-on-work-from-home-criticism-where-did-you-get-your-amazon-packages">scaling back flexibility to manage productivity</a> and investor apprehensions after pandemic-era overexpansion. Uber&#8217;s leadership team has said that attendance will be tracked, both at the team and individual levels.
Apart from the RTO move, Uber also changed its eligibility criteria for its one-month paid sabbatical from five to eight years of service. This decision generated speedy internal criticism. "This isn't ‘doing the right thing' for your employees," one staffer posted on the company's Q&amp;A forum, as per CNBC. Khosrowshahi and Chief People Officer Nikki Krishnamurthy are scheduled to address employee doubts and queries concerns at an all-hands meeting on Tuesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/25/04/44858177/uber-ceo-dara-khosrowshahi-says-the-two-college-courses-are-absolute-necessity-for-c-suite-aspiring-leaders">Uber CEO Dara Khosrowshahi Says The Two College Courses Are &#8216;Absolute Necessity&#8217; For C-Suite-Aspiring Leaders</a></li>
</ul>
Image Via Shutterstock

UBER

Uber Orders Employees Back To Office 3 Days A Week: Good 'Is Not Going To Be Good Enough,' Says CEO Dara Khosrowshahi

<ul>
<li>JetCool's SmartSense Coolant Distribution Unit (CDU) liquid-to-liquid solutions support hyperscale, enterprise, and colocation applications</li>
<li>Supported by Flex's advanced manufacturing capabilities and services to enable customers to rapidly scale liquid cooling infrastructure</li>
<li>Flex will highlight the CDU at the 2025 OCP EMEA Summit in booth A18</li>
</ul>

FLEX

Flex Expands JetCool Portfolio With In-Rack SmartSense CDU Delivering Up To 300kW Per Rack

In summary:
<ul>
<li>We urge shareholders not to be misled by the Vivo group's attempts to relitigate an unappealable verdict by the Privy Council, rewrite history, and paint a fictitious picture of the last few years' events, while simultaneously attempting to line their own pockets at your expense.</li>
<li>It is our fiduciary duty to vigorously defend against the hostile actions and lawsuits by the Vivo group so that we may ensure fairness for all shareholders, restore integrity and trust, and position SINOVAC for the future.</li>
<li>We are confident we will prevail, and we want to emphasize that we are urgently working to make things right as soon as possible to mitigate against further chaos and litigation, after what we have all endured over the last seven years.</li>
</ul>

SINOVAC Board Responds To Vivo Capital's Legal Threats, Defends $55/Share Special Dividend For Common Shareholders

General

NTRS

Northern Trust Inks Service Agreement With Ecosystem Certification Organization (ECO) To Provide Recordation And Settlement Services For Digital Carbon Credit Units Issued To Project Developers Under The Natural Forest Standard (NFS)

As part of the carve-out transaction, the management team and all employees currently operating the EMEA colocation business within STACK are expected to migrate with the Company, which will be re-branded and will no longer bear the "STACK Infrastructure" name or logo. STACK will continue its growth trajectory with a focus on hyperscale development and operations across key EMEA markets

Apollo To Acquire Seven-Asset European Colocation Portfolio From STACK Infrastructure In Strategic Carve-Out Transaction

<figure class="table"> 
<table>
<tbody>
<tr>
<td>REAFFIRMING FY25 GUIDANCE[1,4]</td>
</tr>
</tbody>
</table>
</figure>
Outlook for FY25 reflects our current assessment of market conditions. Unless stated otherwise, guidance is on an adjusted comparable[4] &amp; FX-neutral basis.
Revenue: growth of approx.~4%
Balanced between volume &amp; revenue per unit case
Two fewer selling days in Q1, one extra in Q4
Cost of sales per UC: comparable growth of ~2%
Expect broadly flat commodity inflation (hedged at ~90% for FY25)
Concentrate directly linked to revenue per UC through incidence pricing
Operating profit: growth of ~7%
Comparable effective tax rate: ~26%
CAPEX: ~5% of revenue (incl. leases)
Comparable free cash flow: at least €1.7bn
Dividend payout ratio: ~50%[7] based on comparable EPS
Share buyback: €1bn over 12 months from February 2025

Guidance

Coca-Cola European Partners plc Ordinary Shares

CCEP

Coca-Cola Europacific Partners Reaffirms FY25 Outlook With ~4% Revenue Growth, ~7% Profit Increase, 2% Cost Inflation, And €1.7B+ Free Cash Flow

Coca-Cola Europacific Q1 Revenue €4.689B (+5% YoY), Adjusted Comparable Volume -0.8%

The President Donald Trump administration&#8217;s request for Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) to conduct new clinical trials for its COVID-19 vaccine.
What Happened: Novavax announced Monday that the Food and Drug Administration requested a new clinical trial before granting full approval for its protein-based COVID-19 shot, despite the company believing its vaccine remains &#8220;approvable.&#8221; 
The requirement came shortly after FDA Commissioner Marty Makary characterized the annually updated vaccine as &#8220;a new product&#8221; requiring new studies.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">To be clear, this is a new product that Novavax is trying to introduce to the market with a study of a different product from 2021. New products require new clinical studies. Under this administration, we are prioritizing the Gold Standard of Science&#8211;not what saves pharma… <a href="https://t.co/1f7NvJ9qEJ">pic.twitter.com/1f7NvJ9qEJ</a>
&mdash; Dr. Martin Makary (@DrMakaryFDA) <a href="https://twitter.com/DrMakaryFDA/status/1916253910039429309?ref_src=twsrc%5Etfw">April 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The situation developed following leadership changes at the FDA, including the departure of the agency&#8217;s longtime Vaccine Chief over disagreements with Health Secretary Robert F. Kennedy Jr. 
Industry experts note the FDA had been on track to approve Novavax&#8217;s application by April 1, but Trump appointees directed a pause, the Associated Press <a href="https://apnews.com/article/vaccine-novavax-fda-trump-covid-study-4b4465ad77cfb0554b27b7d59c40ae32">reported</a>, citing anonymous sources.
See Also: <a href="https://www.benzinga.com/general/entertainment/25/04/45059675/mrbeast-sparks-outrage-with-100-men-vs-gorilla-post-on-elon-musks-x-peta-claps-back-try-100-reasons-to-leave-animals">MrBeast Sparks Outrage With &#8216;100 Men Vs Gorilla&#8217; Post On Elon Musk&#8217;s X — PETA Claps Back: &#8216;Try 100 Reasons To Leave Animals&#8230;&#8217;</a>
Why It Matters: A United States Department of Health and Human Services spokesman suggested all COVID-19 vaccines could face stricter requirements, stating: &#8220;The urgency to rush approval of boosters without normal oversight no longer exists.&#8221;
Preliminary results from <a href="https://www.benzinga.com/general/biotech/25/04/44824383/novavax-covid-vaccine-shows-milder-side-effects-than-pfizer-biontechs-shot-study">the SHIELD-Utah study</a> showed Novavax&#8217;s 2024-2025 formula targeting the JN.1 strain produced fewer and less severe side effects compared to Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and BioNTech SE&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) mRNA shots.
Former Health Secretary Xavier Becerra defended the safety record of COVID-19 vaccines, noting: &#8220;We had put some 700 million COVID vaccines into the arms of Americans. That&#8217;s a pretty good size clinical trial.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/insider-trades/25/04/45059696/airbnb-billionaire-joe-gebbia-buys-over-1-million-worth-of-tsla-stock-ahead-of-elon-musks-robotaxi-launch-in-june">Airbnb Billionaire Joe Gebbia Buys Over $1 Million Worth Of TSLA Stock Ahead Of Elon Musk&#8217;s Robotaxi Launch In June</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Health Care

BNTX

MRNA

NVAX

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

The Chinese commerce ministry stated that U.S.-imposed tariffs have adversely affected Chinese airlines and Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>). The ministry has called on Washington to consider the grievances of these companies and promote a stable trade environment.
What Happened: This marks Beijing&#8217;s first remark on the tariffs&#8217; impact on the aviation sector since Boeing returned three 737 MAX planes, initially stationed in China for delivery to Chinese customers, back to the U.S,, Reuters reported on Tuesday.
Last week, Boeing disclosed that due to the tariffs, multiple Chinese customers have refused to accept delivery of new planes, leaving the company to find new buyers for potentially dozens of aircraft. Beijing has also signaled concern over the consequences of the trade war.
The ministry underscored China&#8217;s readiness to back normal business collaboration between the two countries and urged&nbsp;Washington to create a predictable&nbsp;trade and investment environment. &#8220;China&#8217;s&nbsp;affected airlines and Boeing have&nbsp;suffered greatly,&#8221; the ministry noted, emphasizing that the U.S. tariffs have&nbsp;disrupted global supply chains, air&nbsp;transport, and investment activities.
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/04/45038824/treasury-secretary-scott-bessent-says-its-up-to-china-to-de-escalate-trade-tensions-india-to-be-the-first-trade-d" target="_blank" rel="noreferrer noopener">Treasury Secretary Scott Bessent Says It&#8217;s Up To China To &#8216;De-Escalate&#8217; Trade Tensions, India To Be The &#8216;First Trade Deal&#8217; To Be Signed</a>
Why It Matters: Beijing recently instructed Chinese airlines to halt new Boeing orders and get approval for pending deliveries, making the company the latest U.S. firm affected by the U.S.-China trade war. 
The U.S. tariffs have led to a significant <a href="https://www.benzinga.com/markets/equities/25/04/45032435/trump-tariffs-prompt-suspension-of-chinese-factory-operations-and-shift-to-new-markets">disruption </a>in the global supply chain. This development has had a ripple effect across global supply chains and threatened millions of jobs. Chinese manufacturers have had to suspend operations and seek alternative markets due to the impact of these tariffs. The country is also at risk of losing nearly 16 million manufacturing jobs amid the escalating trade tensions, as per Goldman Sachs.
Nevertheless, in a bid to ease trade tensions, China has begun <a href="https://www.benzinga.com/news/global/25/04/45004954/china-reportedly-begins-exempting-key-us-imports-from-tariffs-including-pharma-and-aerospace-parts">exempting </a>some U.S. imports from high tariffs. Companies in China have been asked by officials to identify essential U.S. goods that are difficult to replace. Some pharmaceutical imports and aerospace&nbsp;parts, including engines and landing&nbsp;gear, have already been exempted from the 125% tariffs. French aircraft engine maker, Safran confirmed that China granted tariff exemptions on certain aerospace equipment parts, including engines and landing gear.
Boeing closed 2.44% higher on Monday <a href="https://www.benzinga.com/25/04/45047782/boeing-stock-jumps-on-bernstein-upgrade-is-the-company-back-on-track">following </a>Bernstein's upgrade of the stock from a Market Perform to an Outperform rating and an increase in its price target from $181 to $218.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/events/25/04/44971154/trump-fails-to-impress-americas-young-shows-poll-as-they-still-favor-biden-only-15-think-us-on-right-track" target="_blank" rel="noreferrer noopener">Trump Fails To Impress America&#8217;s Young, Shows Poll As They Still Favor Biden — Only 15% Think US On Right Track &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Economics

China Breaks Silence On Tariff Impact, Says Trump Policies Are Hurting Its Airlines And Boeing

<ul>
<li>European Commission converts conditional approval of FILSPARI (sparsentan)&nbsp;into standard marketing authorization for the treatment of IgA Nephropathy (IgAN)</li>
<li>Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025</li>
<li>EU approval is based on the complete data set from the phase-III PROTECT study</li>
</ul>

TVTX

Reported Earlier, CSL Vifor And Travere Secure Standard EU Approval For FILSPARI In IgA Nephropathy Following CHMP Recommendation

<ul>
<li>HTWO Energy Savannah will serve Hyundai's new Hyundai Motor Group Metaplant America (HMGMA), utilizing XCIENT hydrogen heavy-duty fuel cell trucks for Clean Logistics</li>
<li>Phase one to create a scalable Class-8 hydrogen refueling solution, in collaboration with HTWO Logistics (Fleet Operations), HydroFleet (Hydrogen Refueling), and Capital Development Partners (Overall Development)</li>
<li>Phase two plans include commercial vehicle electric charging capability</li>
<li>HTWO Energy Savannah marks a significant step forward in the decarbonization of emissions-intensive port operations and major logistics corridors</li>
</ul>

HYMTF

Reported Earlier, Hyundai Announces HTWO Energy Savannah To Power Zero-Emission Heavy-Duty Trucking Near Port Of Savannah

The funds from this operation are intended to be allocated to non-investment expenses, in accordance with the Resolution issued by the MHCP and the company's 2025 financing plan and help reach the Gross Debt/EBITDA target for the year.

Reported Earlier, Ecopetrol Secures Ministry Authorization For $500M Loan Agreement With Banco Santander

Gerdau (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGB#NYSE">GGB</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.10 by 37 percent. This is a 42.73 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $2.97 billion which beat the analyst consensus estimate of $2.57 billion by 15.45 percent. This is a 9.40 percent decrease over sales of $3.27 billion the same period last year.

Earnings Beats

Earnings Misses

Gerdau Q1 EPS $0.06 Misses $0.10 Estimate, Sales $2.97B Beat $2.57B Estimate

Reported Earlier, Telix Gains French Approval For Illuccix, Expanding Access To PSMA-PET Imaging For Prostate Cancer Diagnosis And Management

TACT

Reported Earlier, TransAct Technologies Powers Digital Transformation With Successful BOHA! Terminal 2 Deployment Across 1,400 Convenience Store Locations

Billionaire Joe Gebbia, co-founder of Airbnb Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), has purchased over 4000 Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stocks.
What Happened: Gebbia, who is a member of the company's board of directors, purchased 4000 shares at $256.308, as revealed by an SEC filing on Monday.
Gebbia has been on Tesla's board as an independent director since 2022. He also <a href="https://www.benzinga.com/25/03/44265658/billionaire-airbnb-founder-works-with-elon-musk-at-doge">joined Elon Musk's DOGE</a>, or Department of Government Efficiency, to work on the government's paper-based retirement process.
Why It Matters: The news comes in as Tesla is gearing up for its robotaxi launch in June, which Musk shared at the Q1 earnings call, could feature<a href="https://www.benzinga.com/news/earnings/25/04/44943387/elon-musk-shares-fsd-update-at-tesla-earnings-call-10-to-20-model-ys-will-offer-paid-robotaxi-rides-in-june"> 10 to 20 Model Ys</a> deployed on the first day of operations.
The billionaire also reiterated at the earnings call that he would scale back on his DOGE duties to focus on Tesla, which led to analysts like <a href="https://www.benzinga.com/25/04/44945402/wedbushs-dan-ives-raises-teslas-price-target-to-350-as-musk-promises-to-significantly-reduce-doge-time">Dan Ives setting high price targets</a> on Tesla Stock, as well as the stock itself surging in value.
However, Tesla has been grappling with its fair share of problems, including <a href="https://www.benzinga.com/tech/25/04/44857987/tesla-experiences-151-decline-in-new-vehicle-registrations-in-california-report">declining sales figures </a>in the U.S. <a href="https://www.benzinga.com/25/04/44975755/tesla-sales-decline-28-in-europe-as-ev-car-market-experiences-growth-report">as well as Europe</a>, and a 71% YoY profit plunge for Q1 2025, which showcases what was a difficult quarter for the EV giant. Tesla owners in the U.S. are also battling declining used car values as well as rising insurance premiums amid bouts of vandalism.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="205" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-1024x205.jpg" alt="" class="wp-image-892178" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-1024x205.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-300x60.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-768x154.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-1536x307.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA.jpg 1646w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
TSLA scores well on Momentum and Quality metrics, and has a satisfactory Growth score. However, the stock scores poorly in Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/45002938/tesla-bull-gary-black-says-robotaxi-experiment-in-austin-with-10-20-cars-does-not-warrant-billions-in-valuation-potential">Tesla Bull Gary Black Says Robotaxi &#8216;Experiment&#8217; In Austin With &#8217;10-20&#8242; Cars Does Not Warrant Billions In Valuation Potential</a></li>
</ul>
Image Via Shutterstock

Insider Trades

Tech

ABNB

Airbnb Billionaire Joe Gebbia Buys Over $1 Million Worth Of TSLA Stock Ahead Of Elon Musk's Robotaxi Launch In June

Jimmy Donaldson, popularly known as MrBeast, has waded into a bizarre online debate over the weekend involving a hypothetical fight between 100 men and one gorilla.
What Happened: On Monday, the 26-year-old YouTube megastar took to Elon Musk's X, formerly Twitter, and posted a photoshopped image of himself with gorillas, joking, "Need 100 men to test this, any volunteers?"
The animal rights group PETA (People for the Ethical Treatment of Animals) quickly rebuked him, responding: "100 men vs. a gorilla? Maybe try 100 reasons to leave animals out of your content instead…"
See Also:&nbsp;<a href="https://www.benzinga.com/tech/25/01/43325058/mrbeasts-net-worth-hits-1-billion-but-in-2023-he-promised-to-give-away-all-his-money-what-drives-the-youtubers-philanthropy" target="_blank" rel="noreferrer noopener">MrBeast's Net Worth Hits $1 Billion—But In 2023, He Promised To ‘Give Away' All His Money. What Drives The YouTuber's Philanthropy?</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">100 men vs. a gorilla? Maybe try 100 reasons to leave animals out of your content instead…
&mdash; PETA (@peta) <a href="https://twitter.com/peta/status/1916932465589162414?ref_src=twsrc%5Etfw">April 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The online debate — originally born in Reddit Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) r/whowouldwin forum in 2020 — resurfaced last week and has since spread across X, TikTok, and Facebook, <a href="https://www.usatoday.com/story/tech/2025/04/28/100-men-versus-1-gorilla/83326345007/">reported</a> USA Today.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It&#8217;s Important: MrBeast currently has an <a href="https://www.benzinga.com/personal-finance/25/04/44937545/mrbeast-net-worth-how-much-is-youtubes-biggest-creator-worth-in-april-2025">estimated net worth of $1 billion</a>, per Celebrity Net Worth. This valuation includes income from his vast YouTube presence, his snack brand Feastables, merchandise sales, lucrative sponsorships, and a <a href="https://www.benzinga.com/media/25/02/43996522/mrbeast-lost-millions-on-amazons-beast-games-now-hes-looking-to-raise-hundreds-of-millions-to-take-his-brand-to-the-next-level">major content deal</a> with Amazon.com.
According to Forbes, Donaldson brought in approximately $85 million in 2024 from content creation and brand deals alone.
He has stated in interviews that his total revenue across all ventures falls between $600 million and $700 million annually, with the majority funneled back into producing content, scaling operations, and expanding his team.
Photo Courtesy: Joe Seer On Shutterstock.com
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43078570/mrbeast-unhappy-with-billionaires-silence-on-feeding-the-hungry-after-overwhelming-interest-about-tiktok-purchase-when-i-fundraise-its-crickets" target="_blank" rel="noreferrer noopener">MrBeast Unhappy With Billionaires&#8217; Silence On Feeding The Hungry After Overwhelming Interest About TikTok Purchase: ‘When I Fundraise It&#8217;s Crickets&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"> </a>

Entertainment

RDDT

MrBeast Sparks Outrage With '100 Men Vs Gorilla' Post On Elon Musk's X — PETA Claps Back: 'Try 100 Reasons To Leave Animals...'

Press Releases

Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer's Transgenic Mice

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Alzamend Neuro to Present at the Sequire Investor Summit

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer's Disease to take Place at Massachusetts General Hospital

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

180 Life Sciences

Azitra

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Oragenics

Palisade Bio

Plus Therapeutics

Palatin Techs

Sunshine Biopharma

SILO Pharma

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Theriva Biologics

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Ascendiant Capital

Maxim Group

월요일 주요 미국 지수들은 상승세로 마감했다. 다우존스 산업평균지수는 0.6% 상승한 40,896.53에 마감했고, S&amp;P 500 지수는 거의 1% 상승한 5,608.25에 마감했다. 나스닥은 가장 큰 상승세를 보이며 17,876.77로 거의 1.4% 상승하며 하루를 마감했다.
이들은 하루 동안 소매 거래자와 투자자들의 주목을 받은 주요 종목들이다:
 엔비디아 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
엔비디아는 130달러에서 하루를 마감해 4.35% 상승했으며, 장중 최고가와 최저가는 각각 130달러, 123.42달러이다. 52주 신고가와 신저가는 각각 140.76달러와 39.23달러이다. 골드만삭스는 8월 28일로 예정된 이 회사 실적 발표를 앞두고 엔비디아에 대한 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40443620/goldman-sachs-is-bullish-on-nvidia-ahead-of-earnings-risk-reward-for-ai-stock-favor" target="_blank" rel="noopener" data-google-interstitial="false">낙관적인 입장을 재확인</a>하면서 클라우드 서비스 제공업체들과 기업들의 인공 지능에 대한 수요가 높다는 점을 언급했다.
 어드밴스드 마이크로 디바이시스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)
AMD는 4.52% 상승한 155.28달러에 마감했고, 장중 최고가와 최저가는 각각 155.37달러, 147.72달러이다. 52주 신고가와 신저가는 각각 227.3달러와 93.12달러이다. AMD는 49억 달러규모의 주식과 현금 거래로, 초대규모 컴퓨팅 회사들을 위한 인공 지능 인프라 공급자인 <a href="https://www.benzinga.com/m-a/24/08/40438854/amd-expands-ai-capabilities-acquires-zt-systems-in-major-4-9b-deal" target="_blank" rel="noopener" data-google-interstitial="false">ZT 시스템을 인수</a>하기로 결정한 후 주가가 상승했다.
알자멘드 뉴로 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>)
알자멘드는 188.18% 상승한 5.85달러로 마감했으며, 장중 최고가는 15.06달러, 최저가는 5.72달러였다. 52주 최고가와 최저가는 45달러와 1.84달러이다. 이 회사는 PTSD로 고통받는 환자 치료를 위한 AL001의 최초 2상 임상 연구를 수행하기 위한 계약 연구 목적으로 매사추세츠 종합병원과 <a href="https://www.benzinga.com/24/08/40444701/crude-oil-down-2-alzamend-neuro-shares-spike-higher">파트너십</a>을 맺었다고 발표했다.
팔로알토 네트웍스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>)
팔로알토 네트웍스는 2.77% 상승한 343.36달러로 마감했으며, 장중 최고가와 최저가는 각각 344.48달러, 335.11달러이다. 52주 신고가와 신저가는 각각 380.84달러와 224.64달러이다. 이 회사는 <a href="https://www.benzinga.com/news/earnings/24/08/40449958/palo-alto-networks-q4-earnings-revenue-beat-eps-beat-strong-guidance-500m-added-to-buyback-and-more">4분기 이익</a>을 주당 1.51달러로 보고했는데, 이는 분석가의 예상인 1.41달러를 뛰어넘는 수치이다. 해당 분기 매출은 21억 8,900만 달러로 컨센서스 추정치 21억 6,200만 달러를 넘어섰다. 이 회사는 4분기 연속 이익 및 매출 추정치를 초과했다.
테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
테슬라는 3.12% 상승한 222.86달러로 장을 마감했으며, 장중 최고가는 222.98달러, 최저가는 214.09달러였다. 52주 최고가와 최저가는 278.97달러와 138.8달러이다. 테슬라의 일론 머스크 CEO는 러시아 지도자인 람잔 카디로프(Ramzan Kadyrov)에게 사이버트럭을 &#8216;기증&#8217;했다는 사실을 <a href="https://www.benzinga.com/news/24/08/40434114/elon-musk-denies-donating-tesla-cybertruck-to-ramzan-kadyrov-after-russian-general-showed-off-truck">부인</a>했다.
Photo by WHYFRAME on Shutterstock
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>가 제작했으며 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noopener noreferrer">Shivdeep Dhaliwal</a>가 편집했습니다.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Alzamend Neuro

뉴스

에 대한 최신 뉴스 Alzamend Neuro (NASDAQ:ALZN) 주식

월요일, 8월 19, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌